Mannatech Inc. (MTEX) — Analysis Summary
Mannatech Inc. (MTEX) has a market cap of $15.17M with year-over-year revenue growth of -8.3%. Net margin stands at -14.1%. The stock trades at a P/E ratio of -1.0.
Key Takeaways
- Revenue changed -8.3% year-over-year
- Net margin of -14.1%
- P/E ratio of -1.0
Compared to other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, MTEX posted revenue growth of -8.3% and trades at a P/E of -1.0.
Mannatech Inc. (MTEX)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -1.0x — earnings do not cover interest payments
Shareholder equity is negative, which can signal balance-sheet stress.
Debt/EBITDA at 4.1x — elevated leverage
The latest filing shows negative free cash flow.
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
Sector
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Employees
170
Headquarters
FLOWER MOUND, TX
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$0.80
Dividend Yield
10.27%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.